Investor profile
Eos Advisory has backed 13 European tech companies across 15 funding rounds between 2022 and 2026, joining rounds totalling €73M. Most active in Healthtech and Cleantech. Data as of 6 Aug 2026.
Also recorded as: Eos Advisory LLP
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Bioliberty | UK | 2 | €11M |
| Dxcover | UK | 1 | €11M |
| Naturbeads | UK | 2 | €11M |
| Laverock Therapeutics | UK | 1 | €7.6M |
| TaiSan | UK | 1 |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Dxcover | Series A | €11M | 2023-02 |
| Naturbeads | Series A | €9.4M | 2024-11 |
| Bioliberty | Other | €8.8M | 2026-03 |
| Laverock Therapeutics |
| €5.4M |
| EnsiliTech | UK | 1 | €5.2M |
| Carcinotech | UK | 1 | €4.9M |
| Nami Surgical | UK | 1 | €3.7M |
| Concinnity | UK | 1 | €3.6M |
| Green Bioactives | UK | 1 | €3.0M |
| Neupulse | UK | 1 | €2.9M |
| Waire Health | UK | 1 | €2.3M |
| Chromacity | UK | 1 | €1.2M |
| Seed |
| €7.6M |
| 2025-06 |
| TaiSan | Seed | €5.4M | 2026-07 |
| EnsiliTech | Seed | €5.2M | 2025-08 |
| Carcinotech | Other | €4.9M | 2024-01 |
| Nami Surgical | Seed | €3.7M | 2024-05 |
| Concinnity | Seed | €3.6M | 2024-12 |
| Green Bioactives | Seed | €3.0M | 2022-12 |
